Royal Bank of Canada’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.52M | Sell |
51,224
-7,386
| -13% | -$218K | ﹤0.01% | 3245 |
|
|
2025
Q1 | $1.75M | Sell |
58,610
-37,171
| -39% | -$1.11M | ﹤0.01% | 2756 |
|
|
2024
Q4 | $2.74M | Buy |
95,781
+25,275
| +36% | +$724K | ﹤0.01% | 2456 |
|
|
2024
Q3 | $2.72M | Buy |
70,506
+25,438
| +56% | +$983K | ﹤0.01% | 2450 |
|
|
2024
Q2 | $1.45M | Sell |
45,068
-4,367
| -9% | -$141K | ﹤0.01% | 2838 |
|
|
2024
Q1 | $1.92M | Sell |
49,435
-1,537
| -3% | -$59.6K | ﹤0.01% | 2621 |
|
|
2023
Q4 | $1.57M | Buy |
50,972
+7,722
| +18% | +$238K | ﹤0.01% | 2820 |
|
|
2023
Q3 | $967K | Buy |
43,250
+2,519
| +6% | +$56.3K | ﹤0.01% | 3038 |
|
|
2023
Q2 | $875K | Buy |
40,731
+9,309
| +30% | +$200K | ﹤0.01% | 3106 |
|
|
2023
Q1 | $753K | Buy |
31,422
+9,881
| +46% | +$237K | ﹤0.01% | 3210 |
|
|
2022
Q4 | $500K | Buy |
21,541
+2,917
| +16% | +$67.7K | ﹤0.01% | 3666 |
|
|
2022
Q3 | $299K | Buy |
18,624
+3,329
| +22% | +$53.4K | ﹤0.01% | 3973 |
|
|
2022
Q2 | $270K | Buy |
15,295
+594
| +4% | +$10.5K | ﹤0.01% | 4127 |
|
|
2022
Q1 | $299K | Buy |
14,701
+8,206
| +126% | +$167K | ﹤0.01% | 4264 |
|
|
2021
Q4 | $121K | Buy |
6,495
+2,848
| +78% | +$53.1K | ﹤0.01% | 5263 |
|
|
2021
Q3 | $72K | Buy |
3,647
+537
| +17% | +$10.6K | ﹤0.01% | 5423 |
|
|
2021
Q2 | $74K | Buy |
3,110
+2,410
| +344% | +$57.3K | ﹤0.01% | 5287 |
|
|
2021
Q1 | $17K | Sell |
700
-640
| -48% | -$15.5K | ﹤0.01% | 6009 |
|
|
2020
Q4 | $27K | Sell |
1,340
-960
| -42% | -$19.3K | ﹤0.01% | 5371 |
|
|
2020
Q3 | $48K | Sell |
2,300
-5,975
| -72% | -$125K | ﹤0.01% | 4873 |
|
|
2020
Q2 | $145K | Sell |
8,275
-4,744
| -36% | -$83.1K | ﹤0.01% | 4175 |
|
|
2020
Q1 | $213K | Sell |
13,019
-9,397
| -42% | -$154K | ﹤0.01% | 3812 |
|
|
2019
Q4 | $462K | Buy |
22,416
+966
| +5% | +$19.9K | ﹤0.01% | 3484 |
|
|
2019
Q3 | $246K | Buy |
21,450
+4,175
| +24% | +$47.9K | ﹤0.01% | 3762 |
|
|
2019
Q2 | $227K | Buy |
17,275
+4,350
| +34% | +$57.2K | ﹤0.01% | 3847 |
|
|
2019
Q1 | $196K | Sell |
12,925
-8,751
| -40% | -$133K | ﹤0.01% | 3817 |
|
|
2018
Q4 | $373K | Sell |
21,676
-4,988
| -19% | -$85.8K | ﹤0.01% | 3338 |
|
|
2018
Q3 | $393K | Buy |
26,664
+9,738
| +58% | +$144K | ﹤0.01% | 3489 |
|
|
2018
Q2 | $403K | Sell |
16,926
-11,312
| -40% | -$269K | ﹤0.01% | 3402 |
|
|
2018
Q1 | $721K | Buy |
28,238
+2,437
| +9% | +$62.2K | ﹤0.01% | 2874 |
|
|
2017
Q4 | $476K | Sell |
25,801
-2,628
| -9% | -$48.5K | ﹤0.01% | 3160 |
|
|
2017
Q3 | $298K | Sell |
28,429
-710
| -2% | -$7.44K | ﹤0.01% | 3538 |
|
|
2017
Q2 | $365K | Buy |
29,139
+3,285
| +13% | +$41.1K | ﹤0.01% | 3267 |
|
|
2017
Q1 | $261K | Buy |
25,854
+5,784
| +29% | +$58.4K | ﹤0.01% | 3551 |
|
|
2016
Q4 | $312K | Buy |
20,070
+4,720
| +31% | +$73.4K | ﹤0.01% | 3464 |
|
|
2016
Q3 | $296K | Buy |
15,350
+3,750
| +32% | +$72.3K | ﹤0.01% | 3451 |
|
|
2016
Q2 | $137K | Buy |
11,600
+300
| +3% | +$3.54K | ﹤0.01% | 3960 |
|
|
2016
Q1 | $205K | Buy |
11,300
+10,036
| +794% | +$182K | ﹤0.01% | 3719 |
|
|
2015
Q4 | $35K | Buy |
1,264
+965
| +323% | +$26.7K | ﹤0.01% | 4740 |
|
|
2015
Q3 | $7K | Sell |
299
-153
| -34% | -$3.58K | ﹤0.01% | 5439 |
|
|
2015
Q2 | $8K | Buy |
+452
| New | +$8K | ﹤0.01% | 5624 |
|